Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference25 articles.
1. A phase I–II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer;Arteaga;Clin Cancer Res,2008
2. Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: A promising strategy ready for clinical testing;Baselga;Ann Oncol,2002
3. Epidermal growth factor receptor inhibitors in the treatment of lung cancer: Reality and hopes;Wheatley-Price;Curr Opin Oncol,2008
4. The role of gefitinib in the management of Asian patients with non-small cell lung cancer;Chang;Expert Opin Invest Drugs,2008
5. First- line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations;Sequist;J Clin Oncol,2008
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma;Journal of Medicinal Chemistry;2019-04-11
2. An In Silico Investigation of Potential EGFR Inhibitors for the Clinical Treatment of Colorectal Cancer;Current Topics in Medicinal Chemistry;2019-01-31
3. Design of a GAK/EGFR inhibitor set to interrogate the relationship of EGFR and GAK in chordoma;2018-11-20
4. Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors;European Journal of Medicinal Chemistry;2016-11
5. Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer;Expert Opinion on Investigational Drugs;2014-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3